Clinical trials: Iron Deficiency Anemia in Pregnancy
Severe Postpartum Haemorrhage
Treatment of Women After Severe Postpartum Haemorrhage
The primary purpose of this study is to get explorative information about IV high single dose infusion of iron isomaltoside 1000 compared to RBC transfusion in the treatment of severe PP-IDA evaluated as physical fatigue
- Trial name
- PP-02 (NCT01895205)
- Testing
- Iron isomaltoside 1000, Red blood cell transfusion
- Where
- Denmark
- Volunteers
- 13 people
- Sponsor
- Pharmacosmos A/S
Iron Deficiency Anemia, Pregnancy
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
Double blind, placebo controlled, multicenter randomized trial in pregnant women in the U.S. (N=300) to test the central hypothesis that IV iron in pregnant women with IDA (Hb<11 g/dL and ferritin<30 ng/mL) at 13 - 30 weeks will…
- Trial name
- IVIDA2 (NCT05462704)
- Testing
- Ferric derisomaltose, Ferrous sulfate
- Where
- 8 sites in United States
- Volunteers
- 300 people
- Sponsor
- Women and Infants Hospital of Rhode Island
Anemia, Iron-Deficiency
Iron Deficiency Anemia in Twin Pregnancies
All pregnant women with twin pregnancies were given oral iron according to the current recommended dose. Blood routine and ferritin were monitored during pregnancy to understand the therapeutic effect of oral iron on iron…
- Trial name
- NCT04975074
- Testing
- Iron
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Shengjing Hospital
Iron Deficiency Anemia of Pregnancy, Iron Malabsorption
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
Iron deficiency is the most common cause of anemia in pregnancy worldwide, and, when severe, can have serious consequences for mothers and babies.
- Trial name
- IVIDA (NCT03438227)
- Testing
- Iron dextran, Ferrous sulfate 325mg
- Where
- 2 sites in United States
- Volunteers
- 38 people
- Sponsor
- Indiana University
Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD)
Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
The objectives of this study are to compare the efficacy and safety of repeat doses of intravenous (IV) ferumoxytol with IV iron sucrose for the treatment of IDA in subjects with hemodialysis-dependent CKD.
- Trial name
- NCT01227616
- Testing
- Ferumoxytol, Iron Sucrose
- Where
- 43 sites in United States, Canada and 1 more
- Volunteers
- 296 people
- Sponsor
- AMAG Pharmaceuticals, Inc.
Iron Deficiency (ID), Pregnancy
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
Maternal iron deficiency (ID) and iron deficiency anemia (IDA) is associated with maternal and infant mortality, spontaneous preterm birth, maternal postpartum hemorrhage, and neurocognitive defects in the neonate.
- Trial name
- ProMoms (NCT07076849)
- Testing
- Lactiplantibacillus plantarum 299v
- Where
- United States
- Volunteers
- 250 people, healthy volunteers welcome
- Sponsor
- University of Illinois Chicago
Iron-deficiency, Pregnancy Anemia
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
Maternal iron deficiency anemia is associated with maternal and infant mortality, spontaneous preterm birth, maternal postpartum hemorrhage, and neurocognitive defects in the neonate.
- Conditions
- Iron-deficiency, Pregnancy Anemia, Obesity
- Trial name
- NCT04810546
- Testing
- Jarrow Formulas Oral Bovine Lactoferrin Supplement
- Where
- United States
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- University of Illinois Chicago
Anemia
Intravenous Treatment of Anemia in Pregnancy
The investigators assess and compare the efficacy of anemia treatment in pregnant women with anemia of chronic disease with true iron deficiency and in women with iron deficiency anemia.
- Trial name
- NCT03317210
- Testing
- iron sucrose (200 mg VENOFER®), recombinant human erythropoietin (10,000 U EPREX®)
- Volunteers
- 50 people
- Sponsor
- University of Zurich
Iron Deficiency Anemia, Pregnancy Related
The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.
In this study intermittent dosage of iron supplementation three times a week will be compared to daily dosage in anaemic pregnant women due to iron deficiency.
- Trial name
- FER-IDIP (NCT05278793)
- Testing
- Ferrous fumarate
- Where
- Netherlands
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Martini Hospital Groningen
Anemia, Iron Deficiency, Acute Kidney Injury
Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury
This clinical trial aims to carry out research on the effect on hemoglobin and renal function of intravenous administration of iron dextran as a repletion strategy in patients with iron deficiency anemia and acute kidney injury…
- Trial name
- NCT05960227
- Testing
- Iron dextran
- Where
- 2 sites in Mexico
- Volunteers
- 120 people
- Sponsor
- Hospital Civil de Guadalajara
Iron Deficiency Anemia of Pregnancy
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
This study aims to assess whether administering intravenous iron early in pregnancy, compared to standard oral iron treatment, can enhance hemoglobin levels before delivery and reduce the need for blood transfusions in patients…
- Trial name
- IDA (NCT06366698)
- Testing
- Venofer 200 MG Per 10 ML Injection, Ferrous sulfate
- Where
- United States
- Volunteers
- 900 people, healthy volunteers welcome
- Sponsor
- Arrowhead Regional Medical Center
Iron Deficiency, Folic Acid Deficiency
Relative Bioavailability of Iron and Folic Acid in New Test Supplement
Deficiencies of iron and folic acid during pregnancy can lead to adverse outcomes for the fetus, thus supplements are recommended. Adherence to current tablet-based supplements is documented to be poor.
- Trial name
- NCT00789490
- Testing
- Daminaide 995 - SuppleFem Sprinkles, Materna
- Where
- Canada
- Volunteers
- 18 people, healthy volunteers welcome
- Sponsor
- University of Toronto
Iron Deficiency Anemia
Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing
This study consisted of 60 cases. All the cases of pregnant women are 4 months to 8 months of pregnancy. The cases divided into 30 pregnant women's were given iron supplementation without health education and another 30 were…
- Trial name
- TDI (NCT03279536)
- Testing
- Oral lactoferrin, TDI of LMW iron dextran
- Where
- Egypt
- Volunteers
- 99 people
- Sponsor
- Woman's Health University Hospital, Egypt
Anemia Ferropenic, Risk of Hemoconcentration (Iron Levels >130g/L)
Effectiveness of Adaptation of the Dose of Iron Supplementation in Pregnancy on Maternal-child Health. (ECLIPSES)
Currently, there is no consensus regarding iron supplementation dose that is most beneficial for maternal and offspring health during gestation. This deficit, or excess, of iron prejudices the mother-child wellbeing.
- Trial name
- (ECLIPSES) (NCT03196882)
- Testing
- 40mg/day of iron, 20mg/day of iron, 80mg/day of iron
- Where
- 2 sites in Spain
- Volunteers
- 704 people, healthy volunteers welcome
- Sponsor
- Victoria Arija Val
Iron Deficiency Anemia of Pregnancy
Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy
This study evaluates the efficacy and tolerability of lactoferrin in contrast to ferrous sulphate in the context of iron deficiency anemia with pregnancy.
- Trial name
- NCT03481790
- Testing
- Lactoferrin, ferrous sulphate + folic acid (vitamin B9)
- Where
- Egypt
- Volunteers
- 200 people
- Sponsor
- Ain Shams Maternity Hospital
Epithelial Ovarian Cancer, Anemia
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients
This study tests the hypothesis that IV iron sucrose infusions given to iron deficient ovarian cancer patients prior to debulking surgery can improve pre-operative iron stores and decrease transfusion of packed red blood cells in…
- Conditions
- Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia
- Trial name
- NCT03933813
- Testing
- Iron Sucrose
- Where
- United States
- Volunteers
- 9 people
- Sponsor
- University of Wisconsin, Madison
Iron Deficiency Anemia (IDA), ESRD (End Stage Renal Disease)
Management of Iron Deficiency Anemia in Hemodialysis Patients
The aim of this interventional study is to assess the effectiveness of oral lactoferrin in improving hemoglobin levels and correcting iron deficiency anemia in patients with end-stage renal disease (ESRD) on dialysis and also…
- Trial name
- NCT07706582
- Testing
- Lactoferrin, IV iron sucrose
- Where
- Egypt
- Volunteers
- 108 people
- Sponsor
- Beni-Suef University
Iron Deficiency Anemia of Pregnancy
Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
This study will conducted to evaluate and comparison between the effectiveness, safety and acceptability of lactoferrin alone, ferrous fumarate alone and combination of both for the treatment of mild to moderate IDA during…
- Trial name
- NCT03484845
- Testing
- Lactoferrin and ferrous fumarate
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Assiut University
Iron Deficiency (Without Anemia), Pregnancy Related
Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial
Prevalence of anemia in Asia is more than 50%. All woman who book for antenatal care with non-anaemic iron deficiency (NAID) can be offered therapeutic doses of parentral iron, as a directly observed complete therapy, to prevent…
- Trial name
- FAIR (NCT04228627)
- Testing
- Parentral Iron
- Where
- 3 sites in Pakistan
- Volunteers
- 600 people
- Sponsor
- Services Institute of Medical Sciences, Pakistan
Renal Insufficiency, Chronic, Iron-Deficiency Anemia
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
To evaluate the efficacy of oral ferric maltol compared with placebo in the treatment of IDA in subjects with CKD
- Trial name
- AEGIS-CKD (NCT02968368)
- Testing
- Ferric maltol
- Where
- 27 sites in United States
- Volunteers
- 167 people
- Sponsor
- Shield Therapeutics